Danish bank eyes uncertainties for Demant in 2022

A sales halt of cochlear implants and predicted negative growth in France are behind some of the doubts about Demant’s 2022 guidance, writes an analyst from Jyske Bank.
Photo: Simon Fals
Photo: Simon Fals
by marketwire, translated by daniel pedersen

Danish bank Jyske Bank regards hearing aid manufacturer Demant’s half-year results from 2021 in a positive light, and therefore also the company’s full-year results, but several factors have caused some concerns about the company’s expectations for 2022, writes the bank’s senior equity analyst, Janne Vincent Kjær.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
  • Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
    Must contain at least 2 characters
    Must contain at least 2 characters

    Get full access for you and your coworkers

    Start a free company trial today

    Share article

    Sign up for our newsletter

    Stay ahead of development by receiving our newsletter on the latest sector knowledge.

    Newsletter terms

    Front page now

    Further reading